| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |